Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
12 participants
INTERVENTIONAL
2012-12-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Auxiliary Device- "Minkal", is suggested (by its manufactures) to be able to reduce the soldiers' physiological strain by lowering the absolute load being carried by the soldier. As a result, it may improve the soldier's physiological abilities and performance through enduring missions with heavy loads, and may lead to better protection on the soldier from overuse injuries.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Weight-bearing Measuring Device to Determine Normative Percentage Body-Weight/Weight-Bearing Values and Weight-bearing Gait Characteristics
NCT01112332
Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2
NCT03416348
Assessing Foot Injuries in Infantry Recruits Wearing Different Boots
NCT02810002
The Influence of Heel Wedge Properties on Roll-over of the Intrepid Dynamic Exoskeletal Orthosis (IDEO)
NCT02509819
Sensor Ankle Brace for Special Operations Rehabilitation
NCT07085416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study
The participants will undergo 6 days of study. The first day of the study include medical examination, maximal oxigen consumption day and anthropometric mesurments.
Then The participants will undergo heat tolerance test 5 times (in different days).
first day- without load. second day- with back load of 40% of the body weight. third day- with back load of 40% of the body weight and the Auxilairy Device. fourth day- with back load of 60% of the body weight. fifth day- with back load of 60% of the body weight and the Auxilairy Device. The rectal temperature, skin teperature and heart rate will be mesured each day and compered afterwards.
"Minkal"- Auxiliary device to alleviate backload
The participants will undergo 6 days of study. The first day of the study include medical examination, maximal oxigen consumption day and anthropometric mesurments.
Then The participants will undergo heat tolerance test 5 times (in different days).
first day- without load. second day- with back load of 40% of the body weight. third day- with back load of 40% of the body weight and the Auxilairy Device. fourth day- with back load of 60% of the body weight. fifth day- with back load of 60% of the body weight and the Auxilairy Device. The rectal temperature, skin teperature and heart rate will be mesured each day and compered afterwards.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"Minkal"- Auxiliary device to alleviate backload
The participants will undergo 6 days of study. The first day of the study include medical examination, maximal oxigen consumption day and anthropometric mesurments.
Then The participants will undergo heat tolerance test 5 times (in different days).
first day- without load. second day- with back load of 40% of the body weight. third day- with back load of 40% of the body weight and the Auxilairy Device. fourth day- with back load of 60% of the body weight. fifth day- with back load of 60% of the body weight and the Auxilairy Device. The rectal temperature, skin teperature and heart rate will be mesured each day and compered afterwards.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lack of any acute disease during 2 weeks prior the study.
* Subjects will give their written consent for participating the study after being informed by the study's physician about the study's aims, importance and the possible risks.
Exclusion Criteria
* HR above maximal HR ( calculated as 220-age)
* The subject's will to stop the test.
* The researcher's/doctor's judgment.
21 Years
28 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Corps, Israel Defense Force
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
amit druyan
The Institute of Military Physiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chen Makernatz, MD
Role: PRINCIPAL_INVESTIGATOR
Institute physician
Yuval Heled, PhD
Role: STUDY_DIRECTOR
Director of the military physiology institute, IDF medical corps
Ran Yanovich, MA
Role: STUDY_DIRECTOR
The director's deputy of the military physiology institute, IDF medical corps
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of military physiology
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yuval Heled, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
963-2010-CLIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.